The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
The global Clinical Trials market was valued at US$ 46670 million in 2023 and is anticipated to reach US$ 62370 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.
This report aims to provide a comprehensive presentation of the global market for Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trials.
Report Scope
The Clinical Trials market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company (Partial List):
- IQVIA
- Charles River Laboratory
- ICON Plc
- Labcorp Drug Development
- Parexel
- PPD, Inc. (Thermo Fisher)
- Syneos Health
- Wuxi AppTec Inc.
- Tigermed Consulting
- Boji Medical
- Medpace Holdings, Inc.
Segment by Type
- Phase I
- Phase II
- Phase III
- Phase IV
Segment by Application
- Small Molecules
- Biologics
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trials Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.2.5 Phase IV
1.3 Market by Application
1.3.1 Global Clinical Trials Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Small Molecules
1.3.3 Biologics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trials Market Perspective (2019-2030)
2.2 Clinical Trials Growth Trends by Region
2.2.1 Global Clinical Trials Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Clinical Trials Historic Market Size by Region (2019-2024)
2.2.3 Clinical Trials Forecasted Market Size by Region (2025-2030)
2.3 Clinical Trials Market Dynamics
2.3.1 Clinical Trials Industry Trends
2.3.2 Clinical Trials Market Drivers
2.3.3 Clinical Trials Market Challenges
2.3.4 Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trials Players by Revenue
3.1.1 Global Top Clinical Trials Players by Revenue (2019-2024)
3.1.2 Global Clinical Trials Revenue Market Share by Players (2019-2024)
3.2 Global Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Trials Revenue
3.4 Global Clinical Trials Market Concentration Ratio
3.4.1 Global Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trials Revenue in 2023
3.5 Clinical Trials Key Players Head office and Area Served
3.6 Key Players Clinical Trials Product Solution and Service
3.7 Date of Enter into Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trials Breakdown Data by Type
4.1 Global Clinical Trials Historic Market Size by Type (2019-2024)
4.2 Global Clinical Trials Forecasted Market Size by Type (2025-2030)
5 Clinical Trials Breakdown Data by Application
5.1 Global Clinical Trials Historic Market Size by Application (2019-2024)
5.2 Global Clinical Trials Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Clinical Trials Market Size (2019-2030)
6.2 North America Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Clinical Trials Market Size by Country (2019-2024)
6.4 North America Clinical Trials Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Trials Market Size (2019-2030)
7.2 Europe Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Clinical Trials Market Size by Country (2019-2024)
7.4 Europe Clinical Trials Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trials Market Size (2019-2030)
8.2 Asia-Pacific Clinical Trials Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Clinical Trials Market Size by Region (2019-2024)
8.4 Asia-Pacific Clinical Trials Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Trials Market Size (2019-2030)
9.2 Latin America Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Clinical Trials Market Size by Country (2019-2024)
9.4 Latin America Clinical Trials Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trials Market Size (2019-2030)
10.2 Middle East & Africa Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Clinical Trials Market Size by Country (2019-2024)
10.4 Middle East & Africa Clinical Trials Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Detail
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Clinical Trials Introduction
11.1.4 IQVIA Revenue in Clinical Trials Business (2019-2024)
11.1.5 IQVIA Recent Development
11.2 Charles River Laboratory
11.2.1 Charles River Laboratory Company Detail
11.2.2 Charles River Laboratory Business Overview
11.2.3 Charles River Laboratory Clinical Trials Introduction
11.2.4 Charles River Laboratory Revenue in Clinical Trials Business (2019-2024)
11.2.5 Charles River Laboratory Recent Development
11.3 ICON Plc
11.3.1 ICON Plc Company Detail
11.3.2 ICON Plc Business Overview
11.3.3 ICON Plc Clinical Trials Introduction
11.3.4 ICON Plc Revenue in Clinical Trials Business (2019-2024)
11.3.5 ICON Plc Recent Development
11.4 Labcorp Drug Development
11.4.1 Labcorp Drug Development Company Detail
11.4.2 Labcorp Drug Development Business Overview
11.4.3 Labcorp Drug Development Clinical Trials Introduction
11.4.4 Labcorp Drug Development Revenue in Clinical Trials Business (2019-2024)
11.4.5 Labcorp Drug Development Recent Development
11.5 Parexel
11.5.1 Parexel Company Detail
11.5.2 Parexel Business Overview
11.5.3 Parexel Clinical Trials Introduction
11.5.4 Parexel Revenue in Clinical Trials Business (2019-2024)
11.5.5 Parexel Recent Development
11.6 PPD, Inc. (Thermo Fisher)
11.6.1 PPD, Inc. (Thermo Fisher) Company Detail
11.6.2 PPD, Inc. (Thermo Fisher) Business Overview
11.6.3 PPD, Inc. (Thermo Fisher) Clinical Trials Introduction
11.6.4 PPD, Inc. (Thermo Fisher) Revenue in Clinical Trials Business (2019-2024)
11.6.5 PPD, Inc. (Thermo Fisher) Recent Development
11.7 Syneos Health
11.7.1 Syneos Health Company Detail
11.7.2 Syneos Health Business Overview
11.7.3 Syneos Health Clinical Trials Introduction
11.7.4 Syneos Health Revenue in Clinical Trials Business (2019-2024)
11.7.5 Syneos Health Recent Development
11.8 Wuxi AppTec Inc.
11.8.1 Wuxi AppTec Inc. Company Detail
11.8.2 Wuxi AppTec Inc. Business Overview
11.8.3 Wuxi AppTec Inc. Clinical Trials Introduction
11.8.4 Wuxi AppTec Inc. Revenue in Clinical Trials Business (2019-2024)
11.8.5 Wuxi AppTec Inc. Recent Development
11.9 Tigermed Consulting
11.9.1 Tigermed Consulting Company Detail
11.9.2 Tigermed Consulting Business Overview
11.9.3 Tigermed Consulting Clinical Trials Introduction
11.9.4 Tigermed Consulting Revenue in Clinical Trials Business (2019-2024)
11.9.5 Tigermed Consulting Recent Development
11.10 Boji Medical
11.10.1 Boji Medical Company Detail
11.10.2 Boji Medical Business Overview
11.10.3 Boji Medical Clinical Trials Introduction
11.10.4 Boji Medical Revenue in Clinical Trials Business (2019-2024)
11.10.5 Boji Medical Recent Development
11.11 Medpace Holdings, Inc.
11.11.1 Medpace Holdings, Inc. Company Detail
11.11.2 Medpace Holdings, Inc. Business Overview
11.11.3 Medpace Holdings, Inc. Clinical Trials Introduction
11.11.4 Medpace Holdings, Inc. Revenue in Clinical Trials Business (2019-2024)
11.11.5 Medpace Holdings, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
